Do Patients With High CHA2DS2-VASc Scores Need High Intensity of Anticoagulants After Valve Surgery?

Circ J. 2018 Mar 23;82(4):1186-1194. doi: 10.1253/circj.CJ-17-1172. Epub 2018 Jan 25.

Abstract

Background: Asian patients on warfarin therapy usually have lower international normalized ratio (INR) intensities than those recommended by Western clinical practice guidelines. This study evaluated whether a high INR reduces the incidence of thromboembolism (TE) or bleeding events in Asian patients with high CHA2DS2-VASc scores after valve surgery.Methods and Results:Data of adult patients after valve surgery were retrieved from an integrated healthcare information system of a single hospital between 2014 and 2016. The INR was derived from the closest laboratory data before the index outpatient-clinic visit date. The endpoint of every record was determined as emergency room visit or hospitalization because of TE or bleeding event. A total of 37 TE or bleeding events were retrieved from 8,207 records; the annual incidence rate were 1.2% and 2.8% for low (0-2) and high (3-8) CHA2DS2-VASc score groups, respectively (P=0.007). The incidence rates were lowest for both groups at an INR of 1.5-2.0. High INR intensities did not reduce TE or bleeding incidence. INR >3.0 was associated with increased TE or bleeding incidence in the high-score group (6.8%/year vs. 2.0%/year, P=0.079).

Conclusions: The optimal INR is 1.5-2.5 for low- or high-score Asian patients after valve surgery. INR >3.0 was associated with increased TE or bleeding incidence in the high-score group.

Keywords: Anticoagulation; Chinese; Follow-up study; Valve surgery; Warfarin.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anticoagulants / therapeutic use*
  • Asian People
  • Female
  • Heart Valves / surgery*
  • Hemorrhage / etiology
  • Humans
  • Incidence
  • International Normalized Ratio / standards*
  • Male
  • Middle Aged
  • Postoperative Care / methods*
  • Retrospective Studies
  • Risk Assessment
  • Thromboembolism / etiology
  • Warfarin

Substances

  • Anticoagulants
  • Warfarin